A Study of SH006 Injection Combination Therapy in Patients With Advanced Solid Tumors
Clinical trial NCT07362264 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07362264
- Sponsor
- Nanjing Sanhome Pharmaceutical, Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2026-12-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.